These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 4623893)
1. A dose equivalence study of glybenclamide (daonil)--a new hypoglycaemic agent. Mutalik GS; Mitra D; Oak VR; Nayak NJ J Assoc Physicians India; 1972 Mar; 20(3):229-34. PubMed ID: 4623893 [No Abstract] [Full Text] [Related]
2. Clinical assessment of glybenclamide (daonil) in diabetes mellitus. Tripathy BB; Kar BC; Tej SC; Panda NC; Parija CR J Assoc Physicians India; 1973 Mar; 21(3):263-73. PubMed ID: 4210050 [No Abstract] [Full Text] [Related]
3. [Effect of a new oral drug in the treatment of diabetes mellitus]. Lubetzki J Diabete; 1971; 19(3):185-90. PubMed ID: 5002990 [No Abstract] [Full Text] [Related]
4. A study of comparative effectiveness of oral hypoglycaemic agents in single dose in diabetes mellitus. Ahuja MM; Kumar V J Indian Med Assoc; 1971 Jun; 56(12):366-70. PubMed ID: 5118286 [No Abstract] [Full Text] [Related]
5. Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects. Haupt E; Köberich W; Beyer J; Schöffling K Diabetologia; 1971 Dec; 7(6):449-54. PubMed ID: 5004178 [No Abstract] [Full Text] [Related]
6. [Clinical study of a new sulfonylurea antidiabetic, glibornuride]. Vernet A; Fabre J; Zahnd G Schweiz Rundsch Med Prax; 1972 Dec; 61(52):1599-607. PubMed ID: 4630563 [No Abstract] [Full Text] [Related]
7. [ADH-like mechanism of action of chlorpropamide in diabetes insipidus (a comparison with the antidiuretic effect of other blood glucose decreasing sulfonamides and hydrochlorothiazide)]. Wigger W; Scheler F; Creutzfeldt W Klin Wochenschr; 1970 Jul; 48(14):855-61. PubMed ID: 5001116 [No Abstract] [Full Text] [Related]
8. A clinical evaluation of glibenclamide (HB 419, "Daonil") a new antidiabetic sulphonylurea. Cheah JS Singapore Med J; 1972 Apr; 13(2):87-90. PubMed ID: 4625992 [No Abstract] [Full Text] [Related]
9. Assessment of the need for continued oral therapy in diabetics. Tomkins AM; Bloom A Br Med J; 1972 Mar; 1(5801):649-51. PubMed ID: 5015290 [TBL] [Abstract][Full Text] [Related]
10. [Glibenclamide and diabetes mellitus. 1. Year's clinical experience]. Contreras AR; Gabrielli S; Baigorria L Prensa Med Argent; 1972 May; 59(15):581-3. PubMed ID: 4626172 [No Abstract] [Full Text] [Related]
11. [Behavior of lactate and pyruvate in diabetics treated with a combination of fenformin and sulfonylurea in varying doses. I]. Lunetta M; Presti C; Mughini MT; Mughini L Clin Ter; 1980 Jun; 93(5):525-33. PubMed ID: 6775863 [No Abstract] [Full Text] [Related]
12. [Oral therapy of diabetes mellitus with sulfonylurea derivatives]. Schricker KT; Mpliatis A Med Klin; 1970 Jun; 65(24):1163-6. PubMed ID: 5517342 [No Abstract] [Full Text] [Related]
13. Experience with a new hypoglycemic agent, glibenclamide, HB 419 (Daonil) in diabetes mellitus. Ser I Isr J Med Sci; 1972 Jun; 8(6):887. PubMed ID: 4626318 [No Abstract] [Full Text] [Related]
15. [Role of glibenclamide in the therapy of diabetes]. Parodi FA Minerva Med; 1972 Apr; 63(28):1629-32. PubMed ID: 4623326 [No Abstract] [Full Text] [Related]
17. [Glibornurid in treatment of diabetes mellitus]. Rojszykowa E; Wrzesimski W Pol Tyg Lek; 1974 Jan; 29(2):63-6. PubMed ID: 4820789 [No Abstract] [Full Text] [Related]
18. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures]. Tattersall RB Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219 [No Abstract] [Full Text] [Related]
19. The clinical evaluation of an oral antidiabetic drug. Müller R Aust N Z J Med; 1971 Aug; 1():Suppl 2:39-46. PubMed ID: 5005130 [No Abstract] [Full Text] [Related]
20. Modification of diuresis in the rat by chlorpropamide, glibenclamide and tolbutamide. Foy JM; Lucas PD Experientia; 1975 May; 31(5):570-3. PubMed ID: 237771 [No Abstract] [Full Text] [Related] [Next] [New Search]